Heather Wakelee, MD
Heather Wakelee, MD, will assume the role of President of the International Association for the Study of Lung Cancer (IASLC) at the upcoming IASLC 2021 World Conference on Lung Cancer Denver, Worldwide Virtual Event (WCLC 2021) on September 8 to 14, 2021. Dr. Wakelee has been President-Elect of the organization since 2019.
Commenting on leading IASLC, Dr. Wakelee said: “My interest in IASLC has also been strengthened by the value I place on the international aspects of the discussions. It has been so amazing for me personally to realize that there are people all around the world with parallel lives to mine—they are physicians dedicated to treating patients with lung cancer, and they face a lot of the same challenges as me and share the same sense of excitement while witnessing these incredible advances in the field.”
In addition, newly elected members of the Board of Directors will begin their 4-year terms (2021–2025) at the 2021 World Conference on Lung Cancer. They include the following:
President-Elect: Paul E. Van Schil, MD, PhD, thoracic surgeon at University Hospital of Antwerp
Designated European Pulmonary: Joachim Aerts, MD, PhD, of Erasmus University Medical Center, Rotterdam, Netherlands
Designated Nurses & Allied Health Professionals: Morton Quist, PhD, of University Hospital, Copenhagen
Designated Latin America: Carlos Gil Moreira Ferreira, MD, PhD, of Oncoclinicas Institute, Rio di Janeiro
Medical Oncology: Lecia Sequist, MD, MPH, of Massachusetts General Hospital
Pathology: Ming-Sound Tsao, MD, FRCPC, of Princess Margaret Cancer Centre
Asia/Rest of World: Young Tae Kim, MD, PhD, of Seoul
National University
Medical Oncology: Open: Jhanelle Gray, MD, of Moffitt Cancer Center
Multispecialty, Multiregional, Female: Paula Ugalde, MD, of University Institute of Cardiology & Pneumology, Quebec City, Canada.
